BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 30697502)

  • 1. Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease.
    Mandal A; Bhattarai B; Kafle P; Khalid M; Jonnadula SK; Lamicchane J; Kanth R; Gayam V
    Cureus; 2018 Nov; 10(11):e3626. PubMed ID: 30697502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes.
    Sanyal D; Mukherjee P; Raychaudhuri M; Ghosh S; Mukherjee S; Chowdhury S
    Indian J Endocrinol Metab; 2015; 19(5):597-601. PubMed ID: 26425466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of elevated liver enzymes and its relationship with type 2 diabetes mellitus in North Indian adults.
    Alam S; Raghav A; Reyaz A; Ahsan A; Ahirwar AK; Jain V; Agarwal S; Tripathi P
    Metabol Open; 2021 Dec; 12():100130. PubMed ID: 34622192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.
    Arora A; Sharma P
    J Clin Exp Hepatol; 2012 Jun; 2(2):145-55. PubMed ID: 25755423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Verma S; Jensen D; Hart J; Mohanty SR
    Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embedding assessment of liver fibrosis into routine diabetic review in primary care.
    Mansour D; Grapes A; Herscovitz M; Cassidy P; Vernazza J; Broad A; Anstee QM; McPherson S
    JHEP Rep; 2021 Aug; 3(4):100293. PubMed ID: 34179738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.
    Sinha R; Lockman KA; Homer NZM; Bower E; Brinkman P; Knobel HH; Fallowfield JA; Jaap AJ; Hayes PC; Plevris JN
    JHEP Rep; 2020 Oct; 2(5):100137. PubMed ID: 32775974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes.
    Altalebi RR; Al-Hussaniy HA; Al-Tameemi ZS; Al-Zobaidy MA; Albu-Rghaif AH; Alkuraishy HM; Hedeab GM; Azam F; Al-Samydai AM; Naji MA
    J Med Life; 2023 Jan; 16(1):42-47. PubMed ID: 36873135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on Alanine Aminotransferase in Patients of Type 2 Diabetes Mellitus.
    Ahamed F; Karim MR; Haque MA; Rashid MH; Habib MA; Moniruzzaman M; Ekram MS
    Mymensingh Med J; 2021 Apr; 30(2):343-350. PubMed ID: 33830112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
    Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in the Association Between AST/ALT and Incidence of Type 2 Diabetes in Japanese Patients with Nonalcoholic Fatty Liver Disease: A Retrospective Cohort Study.
    Zhang C; Xu Q; Xu C; Yang K; Xia T; Hasi W; Hao M; Kuang H
    Endocr Res; 2024 Jan; 49(1):1-11. PubMed ID: 37752709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population.
    Qiu J; Kuang M; He S; Yu C; Wang C; Huang X; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1302322. PubMed ID: 38125795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.
    Bazick J; Donithan M; Neuschwander-Tetri BA; Kleiner D; Brunt EM; Wilson L; Doo E; Lavine J; Tonascia J; Loomba R
    Diabetes Care; 2015 Jul; 38(7):1347-55. PubMed ID: 25887357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
    Williams KH; Sullivan DR; Nicholson GC; George J; Jenkins AJ; Januszewski AS; Gebski VJ; Manning P; Tan YM; Donoghoe MW; Ehnholm C; Young S; O'Brien R; Buizen L; Twigg SM; Keech AC
    Metabolism; 2016 May; 65(5):783-793. PubMed ID: 27085785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.